Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Video
May 22, 2021
| Erica Klinger
McKenzie's Story – Savings from Generic Medicines
Video
May 22, 2021
| Erica Klinger
Michelle's Story — Savings from Generic Medicines
Blog
May 21, 2021
| Jewel Smith
Member Spotlight: Lachman Consultant Services, Inc.
Blog
May 18, 2021
| Erica Klinger
Doug Is on the Links
Press Release
May 17, 2021
| Rachel Schwartz
Monét Stanford Joins AAM as Director, Policy
Blog
May 16, 2021
| Erica Klinger
McKenzie Is Dancing in the Air
Blog
May 12, 2021
| Erica Klinger
Eric Is Spending Time With His Grandchildren
Blog
May 10, 2021
| Erica Klinger
Raeanne Went Back to School
Blog
May 6, 2021
| Erica Klinger
Michelle Is Seeing the World
Press Release
Apr 29, 2021
| Rachel Schwartz
AAM Statement on The Protecting Access to Affordable Medicines Act
Press Release
Apr 27, 2021
| Rachel Schwartz
AAM Statement on the Ensuring Access to Lower-Cost Medicines for Seniors Act
Press Release
Apr 22, 2021
| Rachel Schwartz
SB 764 Will Hurt Oregon's Most Vulnerable Patients
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action